
Editorials - Page 8 - Medscape
Heliox Redux Helium is an inert, colorless gas. It was discovered by spectroscopic methods during an eclipse of the sun in India in 1868 and, thus, was named from the Greek word helios, which ...
Heliox Treatment: Effective for Children with Asthma? - Medscape
Heliox more effective than oxygen in 30 children studied. However, some factors call into question the results of the trial. Additional, higher powered studies needed.
Editorials - Page 9 - Medscape
Heliox for Status Asthmaticus? In this issue of CHEST (see page 891), Carlos and Gustavo Rodrigo review studies that examine the clinical efficacy of heliox for the management of patients with ...
VNS Effective, Durable for Severe Resistant Depression - Medscape
2 days ago · In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to emerge in late responders.
Better Outcomes With CBT Plus Quetiapine for Mood Disorders
Jan 16, 2026 · Adding cognitive behavioral therapy to quetiapine in mood disorders is linked to reduced suicide risk and depressive symptoms vs quetiapine alone, a new study shows.
Quick Take: Pulmonary Embolism - Medscape
Dr Neena Chandrasekaran discusses pulmonary embolism.
Anti-inflammatory Targets for HS Likely Vary by Patient
Dec 30, 2025 · The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies individualized for disease phenotype.
New Data: The Most Promising Treatments for Long COVID - Medscape
A collection of common and new medications is showing good results against the constellation of symptoms that individualize long COVID. Here’s the latest.
NICE Recommends New CAR-T Therapy for Adult ALL - Medscape
NICE has recommended obecabtagene autoleucel for adults with relapsed or refractory B-cell ALL, offering a potentially more effective option to existing therapies.
Phase 3 Data Support Oral Therapy for Psoriasis - Medscape
Nov 12, 2025 · A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis at a level similar to a biologic.